Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b+/F4/80+ myeloid cell recruitment

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Leukemia

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2011.203PMID 21931322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.

  2010cited by this paper
• Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.

  2009cited by this paper
• Eosinophils and Oral Squamous Cell Carcinoma: A Short Review

  2009cited by this paper
• Stromal gene signatures in large-B-cell lymphomas.

  2008cited by this paper
• Polarized immune responses differentially regulate cancer development

  2008cited by this paper
• Inflammatory cells and immune microenvironment in malignant lymphoma

  2008cited by this paper
• The plasminogen fibrinolytic pathway is required for hematopoietic regeneration.

  2007cited by this paper
• Triggering of T-cell leukemia and dissemination of T-cell lymphoma in MMP-9-deficient mice

  2007cited by this paper
• Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation

  2007cited by this paper
• Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells

  2007cited by this paper
• Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes

  2006cited by this paper
• Macrophages regulate the angiogenic switch in a mouse model of breast cancer.

  2006cited by this paper
• Plasminogen activation and cancer

  2005cited by this paper
• VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

  2005cited by this paper
• Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9–mediated progenitor cell mobilization

  2005cited by this paper
• Prognostic value of matrix metalloproteinases (MMP‐2 and MMP‐9) in Hodgkin's and non‐Hodgkin's lymphoma

  2004cited by this paper
• Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression

  2004cited by this paper
• Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases

  2003cited by this paper
• Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency.

  2003cited by this paper
• Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

  2002cited by this paper
• Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin–Reed–Sternberg cells in Hodgkin's disease

  2002cited by this paper
• Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.

  2002cited by this paper
• Eotaxin promotes eosinophil transmigration via the activation of the plasminogen‐plasmin system

  2001cited by this paper
• Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy

  2001cited by this paper
• Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

  2001cited by this paper
• Development of plasmin and plasma kallikrein selective inhibitors and their effect on M1 (melanoma) and HT29 cell lines.

  2000cited by this paper
• MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.

  2000cited by this paper
• MMP-9 Supplied by Bone Marrow – Derived Cells Contributes to Skin Carcinogenesis

  2000cited by this paper
• Matrix metalloproteinases and oral cancer.

  1999cited by this paper
• Reduced transplant arteriosclerosis in plasminogen-deficient mice.

  1998cited by this paper
• Stem cell factor (c-kit ligand) influences eosinophil recruitment and histamine levels in allergic airway inflammation.

  1996cited by this paper
• Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.

  1995cited by this paper
• Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.

  1994cited by this paper
• Loss of receptors for transforming growth factor beta in human T-cell malignancies.

  1994cited by this paper
• Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen.

  1993cited by this paper
• Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.

  1992cited by this paper
• Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin).

  1990cited by this paper
• Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

  1988cited by this paper
• Detection of a unique antigen on radiation leukemia virus-induced leukemia B6RV2.

  1984cited by this paper

• Fibrinolysis-unrelated functions of the plasminogen/plasmin system: A gateway to successful parasitism?

  2026cites this paper
• Exploitation of the fibrinolytic system by B-cell acute lymphoblastic leukemia and its therapeutic targeting

  2024cites this paper
• Fibrinolysis Inhibitors - Potential Drugs for the Treatment and Prevention of Bleeding.

  2020cites this paper
• Markers of inflammation and fibrinolysis in canine lymphoma

  2018cites this paper
• The role of plasmin in the pathogenesis of murine multiple myeloma.

  2017cites this paper
• X-ray crystal structure of plasmin with tranexamic acid-derived active site inhibitors.

  2017cites this paper
• わが師 岡本彰祐・歌子夫妻―WOMAN Trial の朗報を受けて―

  2017cites this paper
• Cancer therapy targeting the fibrinolytic system.

  2016cites this paper
• Active site-directed plasmin inhibitors: Extension on the P2 residue.

  2016cites this paper
• Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.

  2016cites this paper
• The Delay of Corneal Wound Healing by Diclofenac in a Human Ex Vivo Front of the Eye Model and Rabbit Models

  2016cites this paper
• Plasmin inhibitors with hydrophobic amino acid-based linker between hydantoin moiety and benzimidazole scaffold enhance inhibitory activity.

  2016cites this paper
• Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression

  2015cites this paper
• Novel type of plasmin inhibitors: providing insight into P4 moiety and alternative scaffold to pyrrolopyrimidine.

  2015cites this paper
• Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4/S4 interaction on plasmin.

  2014cites this paper
• Recent Advances on Plasmin Inhibitors for the Treatment of Fibrinolysis‐Related Disorders

  2014cites this paper
• Inhibition of plasmin attenuates murine acute graft-versus-host disease mortality by suppressing the matrix metalloproteinase-9-dependent inflammatory cytokine storm and effector cell trafficking

  2014cites this paper
• Juntendo Medical Journal

  2014cites this paper
• Development of new cyclic plasmin inhibitors with excellent potency and selectivity.

  2013cites this paper
• Identification of Interconnected Markers for T-Cell Acute Lymphoblastic Leukemia

  2013cites this paper
• Bone Marrow-Derived CD11b þ Jagged2 þ Cells Promote Epithelial-to-MesenchymalTransitionandMetastasizationin Colorectal Cancer

  2013cites this paper
• Bone marrow-derived CD 11 b + Jagged-2 + cells promote epithelial to mesenchymal transition and metastization in colorectal cancer

  2013cites this paper
• Bone marrow-derived CD11b+Jagged2+ cells promote epithelial-to-mesenchymal transition and metastasization in colorectal cancer.

  2013cites this paper
• α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)*

  2012cites this paper
• The X-ray crystal structure of full-length human plasminogen.

  2012cites this paper
• Natural and Engineered Plasmin Inhibitors: Applications and Design Strategies

  2012cites this paper
• Cell Surface Remodeling by Plasmin: A New Function for an Old Enzyme

  2012cites this paper
• New functions of the fibrinolytic system in bone marrow cell-derived angiogenesis

  2012cites this paper